Results 111 to 120 of about 25,335 (131)

Gender differences in clinical and prescribing characteristics of biologic and targeted synthetic drugs in naïve patients with rheumatoid arthritis: Data from BIOBADASER III registry. [PDF]

Arthritis Res Ther
Vela-Casasempere P, Otero-Varela L, Gómez Sabater S, Caño Alameda R, Campos Fernández C, Calvo-Gutiérrez J, Pérez-Vera Y, Arija SM, Bustabad S, Manero Ruiz J, Ruiz Montesino MD, Ruíz Gutiérrez L, Mera Varela A, Moreno Ramos MJ, Sánchez-Alonso F, Castrejón I.   +15 more
europepmc   +1 more source

Personalized dose reduction strategies for biologic disease-modifying antirheumatic drugs for treating axial spondyloarthritis: a clinical and economic evaluation with predictive modeling. [PDF]

BMC Rheumatol
Binh BH, Phuong NTT, Hang VTT, Nhan NTT, Hoa NTN, Van Dung H.   +5 more
europepmc   +1 more source

Cardiovascular Outcomes of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: A Review of the Current Evidence. [PDF]

Cureus
Sunkara P, Garikipati NA, Nimmagadda R, Cherukuri AMK, Anne H, Chakilam R, Yadav D.   +6 more
europepmc   +1 more source

Association of Rheumatoid Arthritis With Progression of Cognitive Impairment and Risk of Mortality in People With Dementia. [PDF]

Neurology
Mo M, Eriksdotter M, Ajeganova S, Mitra S, Garcia-Ptacek S, Xu H.   +5 more
europepmc   +1 more source

Rituximab, Apremilast, and Upadacitinib as Selected Biosimilar and Targeted Synthetic Disease-Modifying Antirheumatic Drugs with Diverse Mechanisms of Action: Their Current Use in Slowing Down the Progression of Disease. [PDF]

J Clin Med
Kawczak P, Feszak IJ, Bączek T.
europepmc   +1 more source

Gastrointestinal Perforations Associated With JAK Inhibitors: A Disproportionality Analysis of the FDA Adverse Event Reporting System. [PDF]

United European Gastroenterol J
Goldman A, Raschi E, Druyan A, Sharif K, Lahat A, Ben-Zvi I, Ben-Horin S.   +6 more
europepmc   +1 more source

Prevalence of hyperlipidemia in psoriatic arthritis patients in Riyadh, Saudi Arabia. [PDF]

Saudi Med J
AlTalhi K, Alotaiwi S, Alotaibi M, Alhamzi HA, Alrashedi S, Makkawy M, Alokaily F.   +6 more
europepmc   +1 more source

Evolution of treatment options for juvenile idiopathic arthritis. [PDF]

World J Orthop
Ren T, Guan JH, Li Y, Li NN, Li Z.
europepmc   +1 more source

Comparison of the Efficacy and Safety of Disease-Modifying Antirheumatic Drugs Combination Therapies: A Systematic Review and Network Meta-Analysis. [PDF]

Clin Transl Sci
Liu L, Ambe K, Onishi M, Yoshii Y, Makino T, Tohkin M.   +5 more
europepmc   +1 more source

Diverging effects of tumor necrosis factor inhibitors and conventional synthetic disease-modifying antirheumatic drugs on immunosenescence and inflammageing in rheumatoid arthritis: a cross-sectional analysis. [PDF]

Immun Ageing
Schwarz T, Almanzar G, Völkl S, Feuchtenberger M, Leierer J, Schmidt C, Deininger F, Tony HP, Schmalzing M, Prelog M.   +9 more
europepmc   +1 more source